Neurostimulator Offers Relief to Young Man with Down Syndrome and OSA
Nick Lopez, 20, found relief from OSA after receiving Inspire therapy, now FDA-approved for Down syndrome patients as young as 13. Other neurostimulators are in the pipeline.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
